Key Takeaways
- • New Jersey Urology, a private equity-backed urology group that is part of Tennessee-based U.S. Urology Partners, is opening two interventional radiology centers in Monroe and Voorhees, New Jersey.
- • The practice has hired three radiologists, Arun Chockalingam, MD, Gregg Khodorov, MD, MBA, and Haokang Wei, MD, to lead the new facilities.
- • The program is being developed with rad-owned platform company IR Centers, which now operates around 40 radiology centers across the U.S. through partnerships with urologists, orthopedists, and GI specialists.
- • The centers will offer embolization and other image-guided procedures for conditions including benign prostatic hyperplasia, chronic pelvic pain, hemorrhoidal disease, and musculoskeletal concerns.
- • The care model has drawn criticism from some interventional radiologists who worry it cedes too much IR control to other specialties.
Summary
New Jersey Urology, a private equity-backed urology group that is part of the larger Tennessee-based U.S. Urology Partners, is expanding its interventional radiology offerings with the opening of two new treatment centers in New Jersey. According to a statement issued October 19, the centers are located in Monroe and Voorhees and will provide image-guided procedures, including embolization, for enlarged prostates and other clinical concerns across the state.
The practice has hired three radiologists to lead the new facilities: Arun Chockalingam, MD, Gregg Khodorov, MD, MBA, and Haokang Wei, MD. It is working with IR Centers, a rad-owned platform company launched by radiologist and CEO Sandeep Bagla, MD, to develop the program. New Jersey Urology was acquired by U.S. Urology last year. The group plans to treat benign prostatic hyperplasia, chronic pelvic pain, hemorrhoidal disease, and musculoskeletal concerns.
Chidebelu Ufodike, PharmD, chief operating officer of New Jersey Urology, said that integrating interventional radiology into the clinical network will improve coordination of referral, consultation, treatment and follow-up, while offering minimally invasive options in an outpatient setting. Leaders believe the model will improve patient access, reduce reliance on hospital-based care and strengthen operational efficiencies. Gordon A. Brown, DO, president of New Jersey Urology, said the partnership with leading interventional radiologists expands the region's access to minimally invasive therapies.
IR Centers separately announced the opening of another center in July, operated through an agreement with the Michigan Institute of Urology, marking the third IR lab with that physician group in Michigan. The company now reports around 40 radiology centers nationally and previously announced two additional practice partnerships in April. The business model has drawn criticism from some interventional radiologists, who argue it shifts too much control of IR care to other medical specialties.
The practice has hired three radiologists to lead the new facilities: Arun Chockalingam, MD, Gregg Khodorov, MD, MBA, and Haokang Wei, MD. It is working with IR Centers, a rad-owned platform company launched by radiologist and CEO Sandeep Bagla, MD, to develop the program. New Jersey Urology was acquired by U.S. Urology last year. The group plans to treat benign prostatic hyperplasia, chronic pelvic pain, hemorrhoidal disease, and musculoskeletal concerns.
Chidebelu Ufodike, PharmD, chief operating officer of New Jersey Urology, said that integrating interventional radiology into the clinical network will improve coordination of referral, consultation, treatment and follow-up, while offering minimally invasive options in an outpatient setting. Leaders believe the model will improve patient access, reduce reliance on hospital-based care and strengthen operational efficiencies. Gordon A. Brown, DO, president of New Jersey Urology, said the partnership with leading interventional radiologists expands the region's access to minimally invasive therapies.
IR Centers separately announced the opening of another center in July, operated through an agreement with the Michigan Institute of Urology, marking the third IR lab with that physician group in Michigan. The company now reports around 40 radiology centers nationally and previously announced two additional practice partnerships in April. The business model has drawn criticism from some interventional radiologists, who argue it shifts too much control of IR care to other medical specialties.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.